Contemporary Imaging Diagnosis of Cardiac Amyloidosis
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Cardiac amyloidosis is a rare disease that frequently presents as ventricular hypertrophy. However, diagnosis is not always easy or straightforward as there are several myocardial disorders that phenocopy cardiac amyloidosis. Here, we present a narrative review of the current modalities that are actively used or being developed for diagnosis and follow-up of cardiac amyloidosis. Although not all of the findings may be present in those with cardiac amyloidosis, there are some clues in each diagnostic step that help lead to confirmatory diagnosis of cardiac amyloidosis; we believe that cardiologists should be familiar with these clues.
Abstract
Cardiac amyloidosis is a rare disease that frequently presents as ventricular hypertrophy. However, diagnosis is not always easy or straightforward as there are several myocardial disorders that phenocopy cardiac amyloidosis. Here, we present a narrative review of the current modalities that are actively used or being developed for diagnosis and follow-up of cardiac amyloidosis. Although not all of the findings may be present in those with cardiac amyloidosis, there are some clues in each diagnostic step that help lead to confirmatory diagnosis of cardiac amyloidosis; we believe that cardiologists should be familiar with these clues.
참고문헌 (48)
- Merlini G, "Molecular mechanisms of amyloidosis", N Engl J Med, 349, pp.583~596 (2003)
- Kyle RA, "Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989", Blood, 79, pp.1817~1822 (1992)
- Pinney JH, "Systemic amyloidosis in England : an epidemiological study", Br J Haematol, 161, pp.525~532 (2013)
- Mohammed SF, "Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction", JACC Heart Fail, 2, pp.113~122 (2014)
- Cornwell GG 3rd, "Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation", Am J Med, 75, pp.618~623 (1983)
- Treibel TA, "Occult transthyretin cardiac amyloid in severe calcific aortic stenosis : prevalence and prognosis in patients undergoing surgical aortic valve replacement", Circ Cardiovasc Imaging, 9, pp.e005066~ (2016)
- Castaño A, "Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement", Eur Heart J, 38, pp.2879~2887 (2017)
- Lousada I, "Light chain amyloidosis : patient experience survey from the Amyloidosis Research Consortium", Adv Ther, 32, pp.920~928 (2015)
- Mohty D, "Cardiac amyloidosis : updates in diagnosis and management", Arch Cardiovasc Dis, 106, pp.528~540 (2013)
- Murtagh B, "Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement", Am J Cardiol, 95, pp.535~537 (2005)
- Mussinelli R, "Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis", Ann Noninvasive Electrocardiol, 18, pp.271~280 (2013)
- Aljaroudi WA, "Role of imaging in the diagnosis and management of patients with cardiac amyloidosis : state of the art review and focus on emerging nuclear techniques", J Nucl Cardiol, 21, pp.271~283 (2014)
- Lee GY, "Cardiac amyloidosis without increased left ventricular wall thickness", Mayo Clin Proc, 89, pp.781~789 (2014)
- Klein AL, "Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study", Circulation, 83, pp.808~816 (1991)
- Cueto-Garcia L, "Echocardiographic findings in systemic amyloidosis : spectrum of cardiac involvement and relation to survival", J Am Coll Cardiol, 6, pp.737~743 (1985)
- Bellavia D, "Independent predictors of survival in primary systemic(Al)amyloidosis, including cardiac biomarkers and left ventricular strain imaging : an observational cohort study", J Am Soc Echocardiogr, 23, pp.643~652 (2010)
- Quarta CC, "Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis", Circulation, 129, pp.1840~1849 (2014)
- Phelan D, "Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis", Heart, 98, pp.1442~1448 (2012)
- Lee SP, "11C-Pittsburgh B PET imaging in cardiac amyloidosis", JACC Cardiovasc Imaging, 8, pp.50~59 (2015)
- Koyama J, "Prognostic significance of strain Doppler imaging in light-chain amyloidosis", JACC Cardiovasc Imaging, 3, pp.333~342 (2010)
- Buss SJ, "Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis : incremental value compared with clinical and biochemical markers", J Am Coll Cardiol, 60, pp.1067~1076 (2012)
- Siepen FAD, "Predictors of survival stratification in patients with wild-type cardiac amyloidosis", Clin Res Cardiol, 107, pp.158~169 (2018)
- Maceira AM, "Cardiovascular magnetic resonance in cardiac amyloidosis", Circulation, 111, pp.186~193 (2005)
- Syed IS, "Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis", JACC Cardiovasc Imaging, 3, pp.155~164 (2010)
- Lee SP, "Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis", Radiology, 274, pp.359~369 (2015)
- Lee H, "Noncontrast myocardial T1 mapping by cardiac magnetic resonance predicts outcome in patients with aortic stenosis", JACC Cardiovasc Imaging, 11, pp.974~983 (2018)
- Banypersad SM, "Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis : an equilibrium contrast cardiovascular magnetic resonance study", Circ Cardiovasc Imaging, 6, pp.34~39 (2013)
- Karamitsos TD, "Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis", JACC Cardiovasc Imaging, 6, pp.488~497 (2013)
- White JA, "CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis", JACC Cardiovasc Imaging, 7, pp.143~156 (2014)
- Raina S, "Prognostic value of late gadolinium enhancement cmr in systemic amyloidosis", JACC Cardiovasc Imaging, 9, pp.1267~1277 (2016)
- Boynton SJ, "LGE provides incremental prognostic information over serum biomarkers in AL cardiac amyloidosis", JACC Cardiovasc Imaging, 9, pp.680~686 (2016)
- Kotecha T, "Myocardial edema and prognosis in amyloidosis", J Am Coll Cardiol, 71, pp.2919~2931 (2018)
- Martinez-Naharro A, "Magnetic resonance in transthyretin cardiac amyloidosis", J Am Coll Cardiol, 70, pp.466~477 (2017)
- Dungu JN, "CMR-based differentiation of AL and ATTR cardiac amyloidosis", JACC Cardiovasc Imaging, 7, pp.133~142 (2014)
- Kristen AV, "Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging", Amyloid, 22, pp.132~141 (2015)
- VanAntwerp JD, "Technetium-99m-diphosphonate accumulation in amyloid", J Nucl Med, 16, pp.238~240 (1975)
- Perugini E, "Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy", J Am Coll Cardiol, 46, pp.1076~1084 (2005)
- Bokhari S, "(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses", Circ Cardiovasc Imaging, 6, pp.195~201 (2013)
- Rapezzi C, "Role of(99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis", JACC Cardiovasc Imaging, 4, pp.659~670 (2011)
- Kristen AV, "Noninvasive risk stratification of patients with transthyretin amyloidosis", JACC Cardiovasc Imaging, 7, pp.502~510 (2014)
- Klunk WE, "Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B", Ann Neurol, 55, pp.306~319 (2004)
- Bateman RJ, "Clinical and biomarker changes in dominantly inherited Alzheimer's disease", N Engl J Med, 367, pp.795~804 (2012)
- Antoni G, "In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET", J Nucl Med, 54, pp.213~220 (2013)
- Pilebro B, "Positron emission tomography(PET)utilizing Pittsburgh compound B(PIB)for detection of amyloid heart deposits in hereditary transthyretin amyloidosis(ATTR)", J Nucl Cardiol, 25, pp.240~248 (2018)
- Dorbala S, "Imaging cardiac amyloidosis : a pilot study using ¹⁸F-florbetapir positron emission tomography", Eur J Nucl Med Mol Imaging, 41, pp.1652~1662 (2014)
- Law WP, "Cardiac amyloid imaging with 18F-florbetaben PET : a pilot study", J Nucl Med, 57, pp.1733~1739 (2016)
- Park MA, "18F-florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits : autoradiography study", Circ Cardiovasc Imaging, 8, pp.e002954~ (2015)
- Morgenstern R, "18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis", J Nucl Cardiol, 25, pp.1559~1567 (2018)
